$IRD
Opus Genetics (IRD) Insider Trading
Opus Genetics, Inc.Small Cap$355M
Opus Genetics insiders sold $19.6M in the last 12 months, led by Foundation Fighting Blindness Retinal Degeneration Fund, with one purchase of $324K.
View trades →
Insiders (12-Month)
8 Insiders
View trades →
Insider Buys (12-Month)
+$324K
1 insider · 1 buy
Latest Buy
Dec 31, 2025
Gallagher Cam · $324K
Politicians (12-Month)
No politician trades
Recent Insider Trades in IRD
| Type | Insider | Role | Price | Shares | ΔOwn | Value | Filed |
|---|---|---|---|---|---|---|---|
SELL | Schachle Joseph K | COO | $3.56 | 4,767 | −1.6% | -$16,994 | Oct 27, '26 |
SELL | Yerxa Benjamin R | President | $3.54 | 33,189 | −4.7% | -$117,365 | Oct 27, '26 |
SELL10b5-1 | Gagnon Robert E. | CFO | $3.55 | 14,000 | −2.5% | -$49,650 | Oct 27, '26 |
SELL | Magrath George | CEO | $3.58 | 9,591 | −0.5% | -$34,384 | Oct 27, '26 |
SELL | Foundation Fighting Blindness Retinal Degeneration Fund | Director | $4.96 | 556,000 | −14.7% | -$2,755,981 | Oct 2, '26 |
SELL | Gagnon Robert E. | CFO | $4.54 | 28,000 | −4.8% | -$127,212 | Sep 8, '26 |
SELL | Schachle Joseph K | COO | $2.94 | 4,644 | −1.6% | -$13,653 | Jul 27, '26 |
SELL | Yerxa Benjamin R | President | $2.97 | 7,429 | −1.0% | -$22,064 | Jul 27, '26 |
SELL | Gagnon Robert E. | CFO | $2.95 | 7,783 | −1.3% | -$22,942 | Jul 27, '26 |
SELL | Magrath George | CEO | $2.95 | 9,475 | −0.5% | -$27,926 | Jul 27, '26 |
SELL | Foundation Fighting Blindness Retinal Degeneration Fund | Director | $4.35 | 1,700,000 | −31.0% | -$7,395,000 | May 20, '26 |
SELL | Yerxa Benjamin R | President | $5.24 | 7,470 | −1.0% | -$39,121 | Apr 27, '26 |
SELL | Schachle Joseph K | COO | $5.22 | 4,697 | −1.6% | -$24,519 | Apr 27, '26 |
SELL | Magrath George | CEO | $5.22 | 9,511 | −0.5% | -$49,647 | Apr 27, '26 |
SELL | Jayagopal Ashwath | Chief Scientific & Dev. Ofc. | $5.19 | 7,542 | −1.5% | -$39,156 | Apr 27, '26 |
SELL | Gagnon Robert E. | CFO | $5.18 | 7,842 | −1.3% | -$40,658 | Apr 27, '26 |
SELL | Schachle Joseph K | COO | $5.25 | 3,719 | −1.2% | -$19,525 | Mar 18, '26 |
SELL | Zaremba Rabourn Amy | Head of Fin. Quality Assurance | $5.25 | 2,816 | −1.5% | -$14,770 | Mar 18, '26 |
SELL | Magrath George | CEO | $5.21 | 24,438 | −1.4% | -$127,327 | Mar 18, '26 |
SELL | Jayagopal Ashwath | Chief Scientific & Dev. Ofc. | $5.12 | 3,719 | −0.7% | -$19,046 | Mar 18, '26 |
BUY | Gallagher Cam | Director | $1.97 | 164,000 | +8.9% | +$323,693 | Dec 31, '25 |
SELL | Foundation Fighting Blindness Retinal Degeneration Fund | Director | $2.15 | 4,000,000 | −42.1% | -$8,600,000 | Dec 11, '25 |